[Federal Register Volume 76, Number 169 (Wednesday, August 31, 2011)]
[Notices]
[Pages 54235-54236]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-22214]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

[CFDA: 93.360]


Supplement to the FY2010 Single-Source Cooperative Agreement With 
the World Health Organization (WHO)

AGENCY: Biomedical Advanced Research Development Authority (BARDA), 
Office of the Assistant Secretary for Preparedness and Response (ASPR), 
Department of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In FY 2011, HHS/ASPR/BARDA plans to supplement the FY2010 
``Single-Source Cooperative Agreement with the World Health 
Organization (WHO) to Continue Development of Sustainable Influenza 
Vaccine Production Capacity in Under Resourced Nations''. BARDA 
currently funds the development of vaccine manufacturing capacity in 
ten developing and emerging-economy countries worldwide via a 
cooperative agreement with the World Health Organization (WHO). The 
amount of Single Source Award is $6,021,535. The project period is 
September 1, 2011, through August 31, 2012.

SUPPLEMENTARY INFORMATION: The WHO has proven to be a key partner and 
integral to the success of the program, which has been in existence 
since 2006. Continuing the partnership with the WHO will prove critical 
to the long-term viability of this program while bolstering the 
influenza vaccine manufacturing capabilities of resource-poor nations 
and global pandemic preparedness overall.
    Single Source Justification: The International Vaccine Capacity 
Building Program, supported by the Department of Health and Human 
Services, Office of the Assistant Secretary for Preparedness and 
Response, Biomedical Advanced Research and Development Authority was 
developed and has been operational

[[Page 54236]]

since 2006. In light of the threat of an influenza pandemic it was 
originally designed with the goals of bolstering both international and 
domestic pandemic preparedness and response. The fundamental approach 
in achieving these goals has been through the development of the 
influenza vaccine production capabilities of under resourced nations in 
the hopes that they will ultimately be able to produce vaccines to 
protect the local, regional, and international public health. The 
program is supported by a collaborative of U.S. Government agencies, 
international organizations, foreign ministries and/or other foreign 
institutions dedicated to achieving these goals.
    The WHO is the only global organization with the experience and 
scientific standing to accomplish the program goals. It is the 
recognized world health authority within the United Nations system. 
Similarly, the liaison and support functions that the WHO plays within 
the international vaccine production capacity building program cannot 
be duplicated or replicated. Through standing consultation and dialog 
with its members states on all aspects of public health, WHO is the 
only partner able to ensure synchronization of building of production 
capacity in developing countries for influenza vaccine with other 
pandemic preparedness activities and with increase of demand for 
seasonal influenza immunization.
    The WHO's strong collaborative relationships with foreign 
governments, programmatic support, and familiarity with international 
vaccine production institutions have been and will be critical to the 
future viability of this program. Over the history of the International 
Vaccine Production Capacity Building program, the WHO has provided 
unique and invaluable support to the project. Similarly, the WHO has 
also independently funded other nations/institutions working to 
strengthen their influenza vaccine production capacity; also 
demonstrating their commitment to the success of this program. The WHO 
represents a key stakeholder in the implementation of the program; 
providing unique functions, technical and scientific expertise, and 
capabilities that no other organization in the world has.
    Additional Information: The agency program contact is Dr. Rick 
Bright, whom can be contacted at (202) 260-8535 or [email protected].

    Statutory Authority: Section 319L of the Public Health Service 
(PHS) Act, 42 U.S.C. 247d-7e as amended by Title IV of the Pandemic 
and All-Hazards Preparedness Act (PAHPA), Pub. L. 109-417; and the 
Consolidated Appropriations Act, 2010, Pub. L. 111-117.

    Dated: August 25, 2011.
Nicole Lurie,
Assistant Secretary for Preparedness and Response, U.S. Department of 
Health and Human Services.
[FR Doc. 2011-22214 Filed 8-30-11; 8:45 am]
BILLING CODE 4150-37-P